FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
New ATA guidelines for thyroid disease in pregnancy and preconception provide expert updates on testing,...
Stubborn eczema may signal hidden conditions, so the American Academy of Dermatology now urges doctors...
The new American Association of Neurology and American Headache Society guideline outlines migraine preventive pharmacologic...
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn...
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify...
Gene therapy MPS II stalls as the FDA places a clinical hold on RGX-121 after...
Republican lawmakers vote to hold Fauci in contempt of Congress over COVID-19 pandemic handling disputes,...
Trump’s vaccine policy sparks nationwide debate over parental choice and public health risks amid reduced...
The national nursing strategy outlines Australia’s plan to tackle an 80,000 nurse shortfall by 2035,...